Wael Yared was appointed Chief Technology Officer (CTO), Global Head of Research & Development and a member of the Management Board in April 2019.
Wael has over 20 years of research and product development experience, bringing complex product platforms to market across various sectors of human health. He held global R&D leadership responsibilities across automation, liquid handling, microfluidics, imaging and detection, spanning instrument hardware, software and algorithm development, as well as reagents for immunoassay and preclinical molecular imaging.
Prior to joining Tecan, Wael was Chief Technology Officer and Vice President of Corporate Development at US-based BioAnalytix, Inc. From 2010 to 2016, he was Vice President and global R&D Leader of the Life Science & Technology business unit at PerkinElmer Inc. Before that, Wael was CTO and Vice President R&D at VisEn Medical Inc. from early stage of the Harvard Medical School spin-out to its acquisition by PerkinElmer in 2010.
Wael received his PhD from the Massachusetts Institute of Technology (Cambridge, MA, USA) for his work on command language algorithms in robotics, and is a named inventor and author on a number of patents and publications.